Laporan Laba Rugi (TTM)
Laporan Laba Rugi Noxopharm Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 6 | 7 | 6 | 6 | 5 | 4 | 3 | 2 | 2 | 2 | 3 | 3 |
| Change (%) | -17.00 | -2.27 | -2.32 | 3.87 | 3.72 | -5.08 | -5.35 | 14.34 | 12.54 | -6.98 | -7.51 | -17.75 | -21.58 | -19.04 | -23.52 | -1.16 | -1.18 | 10.16 | 9.22 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 7 | 7 | 10 | 13 | 13 | 13 | 10 | 8 | 9 | 10 | 11 | 11 | 8 | 6 | 5 | 3 | 3 | 3 | 4 | 4 |
| Change (%) | -3.41 | 37.64 | 27.34 | 0.19 | 0.19 | -19.16 | -23.70 | 17.36 | 14.80 | 0.80 | 0.80 | -20.40 | -25.63 | -26.72 | -36.46 | 1.70 | 1.67 | 20.29 | 16.87 | |
| % of Revenue | 104.81 | 121.98 | 171.79 | 223.97 | 216.04 | 208.67 | 177.72 | 143.27 | 147.06 | 150.00 | 162.55 | 177.15 | 171.44 | 162.60 | 147.18 | 122.28 | 125.82 | 129.44 | 141.35 | 151.25 |
| Gross Operating Profit | -0 | -1 | -4 | -7 | -7 | -7 | -4 | -2 | -3 | -3 | -4 | -5 | -4 | -2 | -1 | -1 | -1 | -1 | -1 | -1 |
| Change (%) | 279.12 | 219.15 | 68.67 | -2.78 | -2.86 | -32.11 | -47.31 | 24.36 | 19.59 | 16.37 | 14.07 | -23.83 | -31.29 | -38.98 | -63.88 | 14.54 | 12.69 | 54.71 | 35.36 | |
| % of Revenue | -4.81 | -21.98 | -71.79 | -123.97 | -116.04 | -108.67 | -77.72 | -43.27 | -47.06 | -50.00 | -62.55 | -77.15 | -71.44 | -62.60 | -47.18 | -22.28 | -25.82 | -29.44 | -41.35 | -51.25 |
| SG&A | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 |
| Change (%) | -11.91 | 5.45 | 5.16 | -6.59 | -7.06 | 5.95 | 5.62 | -1.96 | -2.00 | -7.50 | -8.11 | -8.61 | -9.42 | -8.05 | -8.76 | -1.90 | -1.94 | 0.37 | 0.37 | |
| % of Revenue | 106.71 | 113.26 | 122.21 | 131.58 | 118.33 | 106.03 | 118.34 | 132.05 | 113.23 | 98.60 | 98.04 | 97.40 | 108.23 | 125.01 | 141.97 | 169.36 | 168.09 | 166.79 | 151.97 | 139.65 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 15 | 14 | 17 | 20 | 20 | 19 | 17 | 15 | 16 | 18 | 17 | 17 | 14 | 11 | 9 | 7 | 7 | 7 | 8 | 8 |
| Change (%) | -7.51 | 21.74 | 17.86 | -2.29 | -2.34 | -10.55 | -11.80 | 7.99 | 7.40 | -2.79 | -2.87 | -16.50 | -19.75 | -18.63 | -22.90 | -0.39 | -0.40 | 9.07 | 8.32 | |
| % of Revenue | 215.06 | 239.66 | 298.54 | 360.22 | 338.86 | 319.05 | 300.63 | 280.14 | 264.59 | 252.51 | 263.89 | 277.12 | 281.35 | 287.91 | 289.37 | 291.71 | 293.98 | 296.31 | 293.39 | 290.96 |
| Operating Income | -8 | -8 | -11 | -15 | -14 | -13 | -12 | -10 | -10 | -11 | -11 | -11 | -9 | -7 | -6 | -5 | -5 | -5 | -5 | -5 |
| Change (%) | 0.74 | 38.93 | 28.02 | -4.65 | -4.88 | -13.06 | -15.02 | 4.47 | 4.28 | -0.04 | -0.04 | -15.79 | -18.74 | -18.41 | -22.57 | 0.01 | 0.01 | 8.52 | 7.85 | |
| % of Revenue | -115.06 | -139.66 | -198.54 | -260.22 | -238.86 | -219.05 | -200.63 | -180.14 | -164.59 | -152.51 | -163.89 | -177.12 | -181.35 | -187.91 | -189.37 | -191.71 | -193.98 | -196.31 | -193.39 | -190.96 |
| Interest Expense | -3 | -3 | -2 | -2 | -2 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 |
| Change (%) | -13.54 | -8.36 | -9.13 | -19.13 | -23.66 | -47.15 | -89.22 | -2.84 | -2.92 | -21.90 | -28.04 | 23.04 | 18.73 | -23.98 | -31.55 | 75.55 | 43.04 | 271.72 | 73.10 | |
| % of Revenue | -43.14 | -44.94 | -42.14 | -39.20 | -30.52 | -22.46 | -12.51 | -1.42 | -1.21 | -1.04 | -0.88 | -0.68 | -1.02 | -1.54 | -1.45 | -1.30 | -2.31 | -3.34 | -11.26 | -17.85 |
| Net Income | -0 | -0 | -5 | -9 | -10 | -11 | -15 | -19 | -17 | -15 | -15 | -15 | -14 | -12 | -8 | -4 | -3 | -2 | -4 | -5 |
| Change (%) | -71.86 | 10,439.47 | 99.05 | 10.11 | 9.18 | 33.06 | 24.84 | -8.53 | -9.33 | -1.37 | -1.39 | -9.73 | -10.77 | -35.25 | -54.44 | -17.64 | -21.41 | 55.44 | 35.67 | |
| % of Revenue | -2.24 | -0.76 | -81.78 | -166.66 | -176.68 | -185.98 | -260.70 | -343.86 | -275.07 | -221.61 | -234.98 | -250.52 | -274.96 | -312.86 | -250.23 | -149.07 | -124.22 | -98.79 | -139.39 | -173.15 |
Source: Capital IQ
